Differing validity of non-invasive thoracic bioimpedance based determination of cardiac index in patients with and without systolic heart failure

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00018964

Enrollment

Registered

2020-03-30

Start date

2018-12-17

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I50

Interventions

Group 1: Patients with systolic heart failure: when a right heart cathetherization is clinically indicated and performed a noninvasive bioimpedance-based measurement of the stroke volume of the heart

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Medically indicated right-heart catheterization with determination of cardiac output/stroke volume.

Exclusion criteria

Exclusion criteria: /

Design outcomes

Primary

Measure	Time frame
Coherence of the bioimpedance-measured cardiac output and stroke volume values with the thermodilution measured values; within 3 days after the clinically indicated thermodilution measurement the bioimpedance-based measurement will be done.	—

Secondary

Measure	Time frame
Coherence of the primary outcome in patient with and without systolic heart failure	—

Countries

Germany

Contacts

Public ContactJens Spiesshoefer

Institut für Schlafmedizin und neuromuskuläre Erkrankungen, Universitätsklinikum Münster

jens.spiesshoefer@ukmuenster.de00492518341119

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 11, 2026